
|Articles|February 27, 2014 (Updated: April 18, 2020)
- NSCLC (Issue 2)
- Volume 2
- Issue 1
Treating Older Patients With NSCLC
Author(s)Chandra P. Belani, MD
Chandra P. Belani, MD, Deputy Director, Penn State Hershey Cancer Institute, Miriam Beckner Distinguished Professor of Medicine, Penn State Hershey College of Medicine, discusses treating older patients who have non-small cell lung cancer
Chandra P. Belani, MD, Deputy Director, Penn State Hershey Cancer Institute, Miriam Beckner Distinguished Professor of Medicine, Penn State Hershey College of Medicine, discusses treating older patients who have non-small cell lung cancer.
Learn more aboutthe treatment of older patients with NSCLC > >
Articles in this issue
about 12 years ago
Crizotinib Resistance in ALK-Positive Lung Cancerabout 12 years ago
Clinical Update: ALK-Positive NSCLCabout 12 years ago
PD-L1 as a Biomarker for Immunotherapy Agents in Lung Cancerabout 12 years ago
Treatment of Elderly Patients With NSCLCabout 12 years ago
Current Challenges in Molecular Testing in NSCLCabout 12 years ago
Individualized Maintenance Therapy for NSCLCabout 12 years ago
Frontline Treatment Considerations in Non-Small Cell Lung Cancer






























